Wound Cleanser Products Market To Reach $2.79 Billion By 2030

Wound Cleanser Products Market Growth & Trends

The global wound cleanser products market size is anticipated to reach USD 2.79 billion by 2030, exhibiting a CAGR of 4.69% during the forecast period, according to a new report by Grand View Research, Inc. The market growth is driven by numerous factors such as increasing incidence of surgical site infection (SSIs), rising healthcare expenditure, and increasing geriatric population.

The market growth is significantly driven by the rising number of surgical site infections (SSIs). Patients undergoing surgery are at an increased risk of surgical site infections (SSIs), which can result in prolonged hospital stays, higher healthcare expenses, and even complications. As a result, healthcare professionals focus on strict infection control procedures, such as using effective wound-cleaning solutions to decrease the incidence of surgical site infections. The market for wound cleanser products is expected to develop as a result of the growing demand for advanced cleansers with antimicrobial properties and moderate but effective formulations from healthcare facilities that improve surgical results and reduce the risk of post-operative infections.

For instance, as per the article by Antimicrobial Resistance & Infection Control in 2022, a study was conducted to estimate SSIs associated with surgical wounds. It was found that, of 338 patients, tertiary hospitals performed 245 (72.5%) and secondary hospitals performed 93 (27.5%) surgical wound procedures for patients. Compared to clean-contaminated wounds, the prevalence of SSI was greater in contaminated wounds, approximately 43.6%. Thus, some of the major factors expected to drive market expansion over the forecast period include an increase in the incidence of traumatic wounds and an increase in the prevalence of SSI.

Additionally, the focus on preventive healthcare practices drives the demand for wound cleaner products. Increasing numbers of healthcare providers are discovering the importance of preventive measures in reducing the incidence of surgical site infections (SSIs), especially during high-risk surgical operations. To reduce the risk of infections, this shift towards preventative treatment involves using stringent wound care protocols, which may include the use of specialty cleansers. Due to this, wound care manufacturers focus on developing novel and effective cleanser formulas that are customized to meet the changing requirements of healthcare facilities. This helps maintain the industry's expansion driven by the rising number of surgical site infections.

 Request a free sample copy or view report summary: Wound Cleanser Products Market Report

Wound Cleanser Products Market Report Highlights

• Based on product, the pulsed lavage systems segment is expected to register the fastest CAGR of 7.82% during the forecast period owing to the growing emphasis on cost-effective healthcare solutions. The need for reducing hospital readmissions is propelling the adoption of pulsed lavage systems, as they contribute to improved wound outcomes and overall patient satisfaction.

• Based on form, the wipes segment is expected to register the fastest CAGR of 5.15% during the forecast period. The soft texture and therapeutic properties of wound cleanser wipes increase the comfort level of patients while having their wounds cleaned, thus, driving the segment growth.

• Based on application, the chronic wounds segment is expected to register the fastest CAGR of 5.20% during the forecast period, owing to the rising geriatric population which is more susceptible to diabetes.

• Based on end-use, the hospitals segment is expected to register the fastest CAGR of 5.05% during the forecast period. Standardized wound care protocols are often employed in hospitals to ensure consistent high-quality patient care. Including specialized wound cleansing products into these procedures promotes adherence to recommended practices and improves clinical results for healthcare practitioners.

Wound Cleanser Products Market Segmentation

Grand View Research has segmented the global wound cleanser products market based on product, form, application, end-use, and region:

Wound Cleanser Products Product Outlook (Revenue, USD Million, 2018 - 2030)

• Wetting Agents

• Antiseptic

• Moisturizers

• Pulsed Lavage Systems

  • Disposable

  • Reusable

  • Semi Disposable

• Others

Wound Cleanser Products Form Outlook (Revenue, USD Million, 2018 - 2030)

• Sprays

• Solutions

• Wipes

• Others

Wound Cleanser Products Application Outlook (Revenue, USD Million, 2018 - 2030)

• Acute Wounds

  • Surgical & Traumatic Wounds

  • Burns

• Chronic Wounds

  • Diabetic Foot Ulcers

  • Pressure Ulcers

  • Venous Leg Ulcers

  • Other Chronic Wounds

Wound Cleanser Products End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Specialty Clinics

• Home Care

• Ambulatory Surgery Centers

• Others

Wound Cleanser Products Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Argentina

  • Mexico

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Wound Cleanser Products Market

• Stryker

• Coloplast Corp

• Smith + Nephew

• B. Braun SE

• Johnson & Johnson Services Inc.

• 3M

• Medline Industries, Inc.

• ConvaTec

• Cardinal Health

• Integra LifeSciences

• Molnlycke Healthcare

• Stryker

• Zimmer Biomet

• Heraeus Holding